Free and protein bound leptin are distinct and independently controlled factors in energy regulation

Diabetologia

Volumn 43, Issue 4, 2000, Pages 438-442

  Brabant, G ^a   Horn, R ^a   Von Zur Muhlen A ^a   Mayr, B ^a   Wurster, U ^a   Heidenreich, F ^a   Schnabel, D ^b   Gruters Kieslich A ^b   Zimmermann Belsing, T ^c   Feldt Rasmussen, U ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c University of Copenhagen   (Denmark)

Author keywords

Bound leptin; Free leptin; Hyperthyroidism; Leptin in CSF; Resting energy expenditure; Weight reduction

Indexed keywords

ANTITHYROID AGENT; LEPTIN; THIAMAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CALORIMETRY; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY; ENERGY EXPENDITURE; FEMALE; HUMAN; HYPERTHYROIDISM; IMMUNORADIOMETRIC ASSAY; NEPHELOMETRY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THYROTOXICOSIS;

EID: 0034005470     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051326     Document Type: Article

References (34)

1. Sinha MK, Caro JF (1998) Clinical aspects of leptin. Vitam Horm 54: 1-30
2. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr (1996) Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 12: 589-593
3. Caro J, Kolaczynski JW, Nyce MR et al. (1996) Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348: 159-161
4. Jequier E, Tappy L (1999) Regulation of body weight in humans. Physiol Rev 79: 451-480
5. Lee GH, Proenca R, Monlez JM et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice Nature 379: 632-635
6. Tartaglia LA, Dembski M, Weng X et al. (1996) Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271
7. Uotani S, Bjorbaek C, Tornoe J, Flier JS (1999) Functional properties of the leptin receptor isoforms. Internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes 48: 279-286
8. Diamond FB, Eichler DC, Duckett G, Jorgensen EV, Shulman D, Root AW (1997) Demonstration of a leptin binding factor in human serum. Biochem Biophys Res Commun 233: 818-822
9. Houseknecht KL, Mantzoros CS, Kuliwat R, Hadro E, Flier JS, Kahn BB (1996) Evidence for leptin binding proteins in serum of rodents and humans: modulation with obesity. Diabetes 45: 1638-1643
10. Sinha MK, Opentanova I, Ohannesian JP et al. (1996) Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98: 1277-1282
11. Ockenga J, Widjaja A, Holtmannspotter M, Schmidt RE, Brabant G (1998) Bound leptin is regulated by tumour necrosis factor-alpha in HIV-infected patients: a potential mediator of wasting? AIDS 12: 2233-2235
12. Lewandowski K, Horn R, O'Callaghan CJ et al. (1999) Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab 84: 300-306
13. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL (1997) Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 82: 3647-3654
14. Prentice AM, Goldberg GR, Murgatroyd PR, Cole TJ (1996) Physical activity and obesity: problems in correcting expenditure for body size. Int J Obes Relat Metab Disord 20: 688-691
15. Dulloo AG, Jacquet J (1998) Adaptive reduction in basal metabolic rate in response to food deprivation in humans: a role for feedback signals from fat stores. Am J Clin Nutr 68: 599-606
16. Wyatt HR, Grunwald GK, Seagle HM et al. (1999) Resting energy expenditure in reduced-obese subjects in the national weight control registry. Am J Clin Nutr 69: 1189-1193
17. Rosenbaum M, Leibel RL, Hirsch J (1997) Obesity. N Engl J Med 337: 396-403
18. Lönn L, Stenlof K, Ottosson M, Lindroos AK, Nystrom E, Sjostrom L (1998) Body weight and body composition changes after treatment of hyperthyroidism. J Clin Endocrinol Metab 83: 4269-4273
19. Korbonits M (1998) Leptin and the thyroid - A puzzle with missing pieces. Clin Endocrinol 49: 569-572
20. Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C (1997) Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab 82: 1632-1634
21. Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P (1997) Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur J Endocrinol 137: 659-663
22. Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K, Saruta T (1998) Serum leptin concentrations in patients with thyroid disorders. Clin Endocrinol (Oxf) 48: 299-302
23. Zimmermann-Belsing T, Dreyer M, Juul Holst J, Feldt-Rasmussen U (1998) The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects. Clin Endocrinol (Oxf) 49: 589-595
24. Ravussin E, Gautier JF (1999) Metabolic predictors of weight gain. Int J Obes Relat Metab Disord 23:[Suppl 1]: 37-41
25. Satoh N, Ogawa Y, Katsuura G et al. (1999) Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48: 1787-1793
26. Collins S, Kühn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS (1996) Role of leptin in fat regulation. Nature 380: 677
27. Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL (1999) Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab 84: 711-717
28. Ozata M, Ozdemir IC, Licinio J (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84: 3686-3695
29. Farooqi IS, Jebb SA, Langmack G et al. (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341: 879-884
30. Heymsfield SB, Greenberg AS, Fujioka K et al. (1999) Recombinant leptin for weight loss in obese and lean adults. A randomized, controlled, dose-escalation trial. JAMA 282: 1568-1575
31. Banks WA, Kastin AJ, Huang W, Jaspan JB, Manness LM (1996) Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-311
32. Nakashima K, Narazaki M, Taga T (1997) Overlapping and distinct signals through leptin receptor (OB-R) and a closely related cytokine signal transducer, gp130. FEBS Lett 401: 49-52
33. Maione D, Di Carlo E, Li W et al. (1998) Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 17: 5588-5597
34. Peters M, Blinn G, Solem F, Fischer M, Meyer zum Buschenfelde KH, Rose-John S (1998) In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. J Immunol 161: 3575-3581